Our study in mice with MCD–induced NASH showed that GJLZ decoction treatment alleviated the hepatic steatosis by regulating the 12-tridecenoic acid–mediated ACC–CPT1A axis to decrease hepatic DNL. The gene discussed is CPT1A; the disease is Hepatic steatosis.